News / Spectrum

CDKL5 gene; cerebrospinal fluid; drug combo for fragile X syndrome

Here is a roundup of autism-related news and research spotted around the web for the week of 16 September.

By Jill Adams
17 September 2024 | 2 min read
comments
https://doi.org/10.53053/ZLVB8184 https://doi.org/10.53053/ZLVB8184 - opens a new tab Cite this article
  • Mice missing one or both copies of the gene CDKL5, which causes CDKL5 deficiency disorder in people, display autism-like traits as early as 2 weeks of age. Autism Research
  • Sensorimotor skills in infants predict self-regulation skills at 12 to 15 months old, and self-regulation skills in infants with autistic siblings predict autism traits at age 3. Developmental Science
  • Autism-linked genes can converge on downstream targets, and convergent effects are more prominent in mature glutamatergic neurons than in neural progenitor cells or GABA-ergic neurons, according to a preprint. bioRxiv
  • Microglia grown from an autistic person’s stem cells and missing the autism-linked gene NRXN1 actively release the proinflammatory cytokine IL-6 and fail to form functional neuronal networks. Brain, Behavior, and Immunity
Research image of microglia.
Uncurbed growth: Microglia missing the NRXN1 gene (right panel) proliferate more (pink stain) than control cells (left panel).
  • Some alterations in resting-state electroencephalograms are shared between people with autism and those with fragile X syndrome, whereas others distinguish the conditions. Journal of Neurodevelopmental Disorders
  • “The complexity of the 16p12.1 deletion and other genomic disorders calls for personalized medicine approaches that fully account for individual-level phenotypic presentation, family history, and genome-wide variant profile towards counseling, management, and potential treatment.” medRxiv
  • The composition of cerebrospinal fluid in embryonic mice is altered in the maternal immune activation mouse model of autism. Journal of Biological Chemistry
  • Combination therapy with lovastatin and minocycline decrease neuronal excitability in people with fragile X syndrome, according to a clinical trial. Spectrum covered earlier results with this drug combination in 2018. Autism Research

Sign up for the weekly Spectrum newsletter to stay current with the latest advancements in autism research.

Recommended reading

Two surreal heads touch each other’s faces.
Spectrum

The case for redefining ‘theory of mind’: Q&A with François Quesque

By Lauren Schenkman
10 October 2024 | 7 min read
Research image of neuronal firing in cultured cells.
Spectrum

Aggression; Angelman syndrome; NLGN3

By Jill Adams
8 October 2024 | 2 min read
Illustration of hands sewing red and white threads in a DNA-like pattern into a blue-gray fabric.
Spectrum

Untangling biological threads from autism’s phenotypic patchwork reveals four core subtypes

By Holly Barker
3 October 2024 | 5 min read

Explore more from The Transmitter

Illustration of a mouse with cheese on its left and a drop of water on its right.
Internal state

Should I stay (and eat) or should I go? How the brain balances hunger with competing drives

By Giorgia Guglielmi
11 October 2024 | 8 min read
Still image of Paul Middlebrooks in conversation with Cristina Savin, Tim Vogels, Gaute Einevoll and Mikel Lepperød.
Brain Inspired Microphone

Cristina Savin and Tim Vogels discuss how AI has shaped their neuroscience research

By Paul Middlebrooks
11 October 2024 | 80 min listen
Licorice and red candy against a lavender background.
Sensory systems

Double-duty neurons in primary olfactory cortex pick up on more than just scent

By Angie Voyles Askham
9 October 2024 | 7 min read